HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emilio Ciusani Selected Research

AZD 6244

1/2020Synergistic Interaction of Histone Deacetylase 6- and MEK-Inhibitors in Castration-Resistant Prostate Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emilio Ciusani Research Topics

Disease

35Neoplasms (Cancer)
07/2022 - 02/2004
19Glioma (Gliomas)
03/2023 - 03/2002
10Glioblastoma (Glioblastoma Multiforme)
12/2021 - 03/2002
8Melanoma (Melanoma, Malignant)
01/2024 - 12/2010
6Carcinoma (Carcinomatosis)
12/2021 - 03/2006
4Multiple Sclerosis
02/2022 - 06/2002
4Inflammation (Inflammations)
12/2021 - 09/2013
3Neoplasm Metastasis (Metastasis)
01/2023 - 01/2009
3Pancreatic Neoplasms (Pancreatic Cancer)
02/2019 - 12/2015
2Alzheimer Disease (Alzheimer's Disease)
09/2023 - 02/2023
2Epilepsy (Aura)
01/2023 - 01/2020
2Meningitis
09/2022 - 01/2009
2Breast Neoplasms (Breast Cancer)
01/2019 - 01/2019
2Drug Resistant Epilepsy
01/2017 - 03/2011
2Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)
01/2017 - 03/2012
2Seizures (Absence Seizure)
01/2017 - 03/2011
2Demyelinating Diseases (Demyelinating Disease)
09/2013 - 02/2006
1Myasthenia Gravis
01/2024
1Brain Diseases (Brain Disorder)
06/2023
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2023
1Brain Neoplasms (Brain Tumor)
01/2023
1Lung Neoplasms (Lung Cancer)
01/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
12/2021
1Mesothelioma
12/2021
1Ketosis
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Disease Susceptibility (Diathesis)
03/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2019

Drug/Important Bio-Agent (IBA)

10Paclitaxel (Taxol)FDA LinkGeneric
02/2019 - 01/2011
7Conditioned Culture MediaIBA
03/2023 - 01/2011
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 02/2004
6Biomarkers (Surrogate Marker)IBA
03/2023 - 12/2010
6Proteins (Proteins, Gene)FDA Link
03/2023 - 04/2008
4LigandsIBA
12/2021 - 01/2005
4Temozolomide (Temodar)FDA LinkGeneric
05/2021 - 01/2004
3Serum AlbuminIBA
09/2023 - 02/2023
3MicroRNAs (MicroRNA)IBA
03/2023 - 10/2015
3Peptides (Polypeptides)IBA
01/2023 - 04/2008
3Cisplatin (Platino)FDA LinkGeneric
01/2023 - 01/2018
3Antineoplastic Agents (Antineoplastics)IBA
12/2021 - 01/2006
3EnzymesIBA
05/2021 - 02/2006
3Drug CombinationsIBA
05/2021 - 06/2014
3Histone Deacetylase InhibitorsIBA
01/2020 - 06/2011
3PlatinumIBA
07/2019 - 01/2018
3matrigelIBA
01/2017 - 01/2006
3AntibodiesIBA
01/2016 - 09/2012
3ChemokinesIBA
06/2014 - 06/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2014 - 01/2005
3Plasminogen Activator Inhibitor 1IBA
02/2006 - 02/2004
2LipidsIBA
01/2024 - 12/2021
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2024 - 01/2020
2VemurafenibIBA
01/2023 - 05/2021
2Immunoglobulin G (IgG)IBA
02/2022 - 09/2013
2Histone Deacetylases (Histone Deacetylase)IBA
01/2020 - 06/2014
2CytokinesIBA
01/2019 - 01/2014
2IntegrinsIBA
12/2018 - 01/2013
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2017 - 06/2014
2CXCR4 Receptors (CXCR4 Receptor)IBA
01/2011 - 05/2004
2HomocysteineIBA
05/2008 - 02/2004
2Topoisomerase I InhibitorsIBA
01/2005 - 03/2002
2Topotecan (Hycamtin)FDA LinkGeneric
01/2005 - 01/2004
1Oleic Acid (Oleate)IBA
01/2024
1Phosphotransferases (Kinase)IBA
01/2024
1Fatty Acids (Saturated Fatty Acids)IBA
01/2024
1glucose-mannose-glucoseIBA
01/2024
1Biological FactorsIBA
06/2023
1KisspeptinsIBA
01/2023
1Kisspeptin-1 ReceptorsIBA
01/2023
1cyclic citrullinated peptideIBA
09/2022
1VaccinesIBA
02/2022
1BNT162 VaccineIBA
02/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
02/2022
18-aminoquinolineIBA
12/2021
1Orlistat (Xenical)FDA Link
05/2021
1Glutamate Receptors (Glutamate Receptor)IBA
05/2021
1perampanelIBA
05/2021
1N-acetylaspartate (N-acetyl aspartate)IBA
01/2021
1isospaglumic acid (NAAGA)IBA
01/2021
1gamma-Aminobutyric Acid (GABA)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1KetonesIBA
01/2021
13-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2020
1ricolinostatIBA
01/2020
1AZD 6244IBA
01/2020
1Cystatin BIBA
01/2020
1Histone Deacetylase 6IBA
01/2020
1Polystyrenes (Polystyrene)IBA
11/2019
1SB 203580IBA
07/2019
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
07/2019
1statticIBA
07/2019
1ProteomeIBA
01/2019
1marycinIBA
01/2019

Therapy/Procedure

13Therapeutics
01/2024 - 03/2002
5Drug Therapy (Chemotherapy)
12/2018 - 01/2007
4Radiotherapy
06/2023 - 05/2012
3Ketogenic Diet
01/2021 - 01/2014
1Activities of Daily Living (ADL)
01/2024
1Castration
01/2020